Ovarian tissue freezing in Hyderabad is a specialised fertility-preservation topic, most relevant to people whose medical treatment may damage ovarian function and who may not be able to complete a standard egg-freezing cycle. The procedure is also called ovarian tissue cryopreservation. It involves surgically removing ovarian cortical tissue, freezing it, and considering future use after treatment when medically appropriate.
How ovarian tissue cryopreservation differs from egg freezing
Egg freezing requires ovarian stimulation and egg retrieval. Ovarian tissue cryopreservation preserves tissue containing many immature follicles and does not require the same stimulation cycle. Because the procedures and future use differ, they should not be presented as interchangeable options.
Who may be considered
ASRM guidance recognises ovarian tissue cryopreservation as an option for selected patients with medical indications, including some people facing gonadotoxic therapy. It may be particularly relevant when treatment is urgent or when the patient is not an appropriate candidate for standard ovarian stimulation.
What the procedure involves
Ovarian tissue is obtained surgically, commonly using minimally invasive techniques. The cortical tissue is processed into pieces and cryopreserved under controlled conditions. The procedure requires coordination among reproductive medicine, surgery, laboratory and the treating oncology or medical team.
How the tissue may be used later
A common future approach is transplantation of thawed tissue back to the patient when clinically appropriate. The goal may include restoration of ovarian endocrine function and the possibility of natural or assisted conception. Suitability depends on the original disease, risk of reintroducing malignant cells and other medical factors.
Risks and limitations
This is a surgical procedure, so surgical and anaesthetic risks should be discussed. The chance of future use and reproductive outcome varies. In some cancers or conditions, reimplantation may not be advisable because of concern about malignant contamination.
Why multidisciplinary counselling matters
Fertility preservation should not delay urgent medical treatment without agreement from the primary treating team. The reproductive specialist and oncologist or other specialist should coordinate timing and safety.
Questions to ask
Ask why ovarian tissue freezing is preferred over egg or embryo freezing, whether there is time for stimulation, how tissue is stored, what future use would involve, and whether the underlying disease affects reimplantation safety. Review MotherToBe’s broader fertility preservation options before consultation.
Why oncology coordination is essential
For patients facing cancer treatment, fertility preservation decisions sit inside a larger treatment plan. The oncologist, reproductive specialist and, when needed, surgeon or haematologist should agree on timing and safety. The goal is to preserve options without compromising treatment of the underlying disease.
Questions about future tissue use
Ask whether future reimplantation would be medically acceptable for your diagnosis, how tissue viability is assessed, what alternatives may exist if reimplantation is unsafe, and what follow-up is needed after cancer or other medical treatment.
Ovarian Tissue Cryopreservation and Fertility Preservation Expertise
At MotherToBe Fertility Clinic & Academy, Madhapur, Hyderabad, fertility care is led by Dr. S. Vyjayanthi, MD, DGO, DNB, MRCOG, MSc (Embryology, UK), CCT (UK), a Subspecialist in Reproductive Medicine & Surgery (RCOG, UK). She serves as Director & Consultant Fertility Specialist at MotherToBe.
Her professional leadership roles include President, Telangana Chapter RCOG; Managing Committee Member, The PCOS Society of India; and Managing Committee Member, Fertility Preservation Society of India.
Her reproductive-medicine and embryology background, together with her Managing Committee role in the Fertility Preservation Society of India, is particularly relevant to multidisciplinary counselling around ovarian tissue cryopreservation.
Read more about Dr. S. Vyjayanthi’s qualifications, leadership roles and Director’s Message on the MotherToBe website.
Frequently Asked Questions
Is ovarian tissue freezing experimental?
It is an established fertility-preservation option in selected clinical situations, but suitability and outcome expectations vary.
Does it require ovarian stimulation?
No, ovarian tissue cryopreservation does not require the standard stimulation cycle used for egg freezing.
Can ovarian tissue be reimplanted after cancer treatment?
Sometimes, but the decision depends on the original disease, remission status and risk of reintroducing malignant cells.
Is it suitable for everyone who wants to delay pregnancy?
No. Planned egg freezing is usually the more relevant option for elective fertility preservation in adults who can undergo stimulation.
Key takeaways
- Choose treatment or a specialist based on diagnosis, evidence, transparency and individual needs—not on unverified ‘best’ or ‘top’ claims.
- Use the target keyword naturally in the title, introduction and relevant context. Do not repeat it mechanically throughout the article.
- Link this article to the relevant MotherToBe service page and link back from related educational content where it genuinely helps the reader.
- Have the medical content reviewed before publication and update it when important clinical guidance changes.
Suggested internal links
Primary service link: fertility preservation options
Doctor profile link: Dr. S. Vyjayanthi – Director’s Message
Also add 2–4 natural internal links to closely related MotherToBe guides where relevant. Vary anchor text and avoid sitewide exact-match repetition.
Medical review and publishing note
Educational content only. Before publication, a qualified fertility specialist should verify the medical statements, local legal/regulatory details, clinic-specific services, doctor credentials and any costs or outcome data. Add the reviewer name, credentials and review date only after a real review. Proposed medical reviewer: Dr. S. Vyjayanthi; publish only after her review and approval of the clinical wording.
References for medical review
- ASRM: Fertility Preservation in Patients with Medical Indications (2026)
- ASRM: Fertility Preservation and Reproduction in Patients Facing Gonadotoxic Therapies (2026)
- International Glossary on Infertility and Fertility Care (2025)